申请人:Mack Robert Stephen
公开号:US20050009777A1
公开(公告)日:2005-01-13
Nucleotide derivatives of formula (1) are described, wherein: G is a hydrogen atom or an optionally substituted aliphatic, heteroaliphatic, cycloaliphatic, polycycloaliphatic, aromatic or heteroaromatic group or a non natural carbon-linked nucleoside as defined herein; G′ is a non-natural carbon-linked nucleoside as defined herein; n is zero, or the integer 1 or 2; m is zero or the integer 1 or 2; and the salts, solvates, hydrates and N-oxides thereof. The compounds are P2Y receptor agonists and are of use in the prophylaxis and treatment of diseases and disorders involving abnormal secretory mechanisms such as inadequate functioning of mucociliary clearance mechanisms or abnormal tear secretion or in the treatment of diseases involving inappropriate cellular glucose uptake.
本文描述了式(1)的核苷酸衍生物,其中:G是氢原子或可选取代的脂肪族,杂脂族,环脂族,多环脂族,芳香族或杂芳香族基团或非天然的碳链核苷酸,如本文所定义;G'是本文所定义的非天然碳链核苷酸;n为零或整数1或2;m为零或整数1或2;以及其盐,溶剂合物,水合物和N-氧化物。这些化合物是P2Y受体激动剂,可用于预防和治疗涉及异常分泌机制的疾病和障碍,例如粘液纤毛清除机制的功能不足或泪液分泌异常,或用于治疗涉及不适当细胞葡萄糖摄取的疾病。